Medical News

RSS

Scientific evidence found linking second-hand smoke exposure to pre-menopausal breast cancer

Until recently, the evidence surrounding the link between breast cancer and tobacco smoke was inconclusive. Now, according to an international panel of experts convened by the Ontario Tobacco Research Unit (OTRU) sufficient scientific evidence exists linking second-hand smoke exposure to pre-menopausal breast cancer and active smoking to breast cancer in women of all ages.

4 Nov 2009

Statins may have negative effects on some cardiac patients, says study

Although statins are widely used to prevent heart attacks, strokes, and other cardiovascular disorders, new research shows that the class of drugs may actually have negative effects on some cardiac patients. A new study presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP), found that statins have beneficial effects on patients with systolic heart failure (SHF), but those with diastolic heart failure (DHF) experienced the opposite effect, including increased dyspnea, fatigue, and decreased exercise tolerance.

4 Nov 2009

Abortion continues to snag health reform legislation, divide lawmakers

The divisive issue of abortions, a lingering hurdle to health reform legislation, is plaguing both House and Senate Democratic leaders, the Los Angeles Times reports. "The delays in both houses reflect the fact that even though Democrats hold solid majorities, significant divisions exist below the surface.

4 Nov 2009

AMFm subsidized malaria drugs to be delivered soon

Subsidized artemisinin-based combination therapies (ACTs) under the Affordable Medicines Facility - malaria (AMFm) program will be available in select countries "in two week's time," SABC News reports. The announcement came Monday at the 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference in Nairobi, Kenya.

4 Nov 2009

Possible cure for Parkinson's disease

Researchers at Iowa State University have found an essential key to possibly cure Parkinson's disease and are looking for others.

4 Nov 2009

Veterans Administration leads in e-health exchange, too

The Veterans Health Administration was at the avant-garde of electronic medical records in the 1980s, and more recently, it's blazed the trail for exchanging health information between providers, the Lawrence (Kan.) Journal-World reports in the third of a 3-part series on EMRs.

4 Nov 2009

Health bills don't go far enough in cutting costs, experts say

"Democrats in Congress are embracing the spirit of President Obama's call to slow the runaway rise of health-care costs but are shying away from some of the most aggressive techniques for achieving that," The Washington Post reports. "Instead of revolutionizing how care is delivered and paid for, experts say, the legislation being shaped takes a cautious approach to reining in costs."

4 Nov 2009

Foamix' emollient foam platform awarded Mexican patent

Foamix Ltd., a leading developer of topical foams for dermatological and gynecological use, announced today that it has been awarded Mexican Patent Registration No. 268451 entitled "Cosmetic and Pharmaceutical Foam." The patent covers Foamix's vehicles, compositions and cosmetic and pharmaceutical uses thereof based on the company's Emollient Foam technology platform.

4 Nov 2009

GenVec receives FDA orphan drug designation for TNFerade

GenVec, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to TNFerade(TM) for the treatment of pancreatic cancer.

4 Nov 2009

MRG's new report on the European markets for small-joint reconstructive implants

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the European market for small-joint reconstructive implants will double by 2014, reaching almost $360 million.

4 Nov 2009

Gastric cancer drug market to double to nearly $1.5 billion in 2018

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the gastric cancer drug market -- driven by the launch of several targeted agents over the next few years -- will more than double from approximately $700 million in 2008 to nearly $1.5 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

4 Nov 2009

Acceleron Pharma commences Phase 1 clinical study of its novel angiogenesis inhibitor

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including red blood cells, bone, muscle, fat, and the vasculature, today announced the initiation of a Phase 1 clinical study of ACE-041, a novel angiogenesis inhibitor that binds to and prevents members of the TGF-β superfamily from signaling through the activin receptor-like kinase 1 (ALK1) receptor.

4 Nov 2009

AGA Medical Holdings receives regulatory product approvals and licenses in China

AGA Medical Holdings, Inc. (AGA Medical) has received regulatory approvals and licenses in China for its AMPLATZER® PFO Occluder and AMPLATZER® Multi-Fenestrated Septal Occluder “Cribriform.”

4 Nov 2009

Conflicts of interest examined between doctors and medical industry, AARP and reform

Health care reform bills include provisions to examine the financial relationships between doctors and the medical industry while some are questioning the AARP's role in reform.

4 Nov 2009

Spray dryer strengthens PharmaForm's portfolio of bioavailability enhancement solutions

PharmaForm, a contract pharmaceutical development and manufacturing organization and a wholly owned subsidiary of Akela Pharma Inc. (TSX: AKL), today announced that it has added aqueous and solvent spray drying to its portfolio of bioavailability enhancement solutions.

4 Nov 2009

EUSA Pharma's PROSTASCINT effective in guiding targeted prostate cancer treatment

EUSA Pharma announced that PROSTASCINT® (capromab pendetide) fusion imaging was shown to effectively guide prostate cancer therapy targeting and dosing and is a significant predictor of disease free survival, according to data presented on Tuesday, November 3, 2009 at the 51st American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting in Chicago, Illinois.

4 Nov 2009

PAH patients face life-threatening risks from medication errors

Pulmonary arterial hypertension (PAH) patients using infused drugs have suffered serious injury or in some cases died from medication errors in hospitals and other inpatient settings, according to a peer-reviewed study by Accredo Health Group and several university hospitals that surveyed doctors, nurses and pharmacists.

4 Nov 2009

GSK's malaria vaccine trial containing Antigenics’ Stimulon adjuvant enrolls more than 5,000 children

Antigenics, Inc. today indicated that GlaxoSmithKline’s (GSK) Phase III malaria vaccine clinical trial, containing Antigenics’ QS-21 Stimulon® adjuvant, has enrolled more than 5,000 children to date and is expected to involve up to 16,000 children. The pivotal efficacy study of RTS,S, the world’s most clinically advanced malaria vaccine, is ongoing in seven African countries.

4 Nov 2009

Watson Pharmaceuticals announces third quarter 2009 financial results

Watson Pharmaceuticals, Inc. today reported net income of $63.0 million, or $0.55 per diluted share for the third quarter ended September 30, 2009. Excluding special items as detailed in the reconciliation table below, adjusted net income for the third quarter was $76.1 million, or $0.66 per diluted share, an increase of $22.1 million or 41 percent over the adjusted net income for the third quarter ended September 30, 2008. As detailed in the attached reconciliation table, adjusted EBITDA for the third quarter was $178.4 million.

4 Nov 2009

Medivir presents OPERA-1 Phase IIa trial data at the AASLD meeting

Data were presented from the phase IIa trial (OPERA-1) for TMC435 at the ongoing 60th annual meeting of the American Association for the Study of Liver Diseases in Boston, USA.

4 Nov 2009

Medical News

Scientific evidence found linking second-hand smoke exposure to pre-menopausal breast cancer

Statins may have negative effects on some cardiac patients, says study

Abortion continues to snag health reform legislation, divide lawmakers

AMFm subsidized malaria drugs to be delivered soon

Possible cure for Parkinson's disease

Veterans Administration leads in e-health exchange, too

Health bills don't go far enough in cutting costs, experts say

Foamix' emollient foam platform awarded Mexican patent

GenVec receives FDA orphan drug designation for TNFerade

MRG's new report on the European markets for small-joint reconstructive implants

Gastric cancer drug market to double to nearly $1.5 billion in 2018

Acceleron Pharma commences Phase 1 clinical study of its novel angiogenesis inhibitor

AGA Medical Holdings receives regulatory product approvals and licenses in China

Conflicts of interest examined between doctors and medical industry, AARP and reform

Spray dryer strengthens PharmaForm's portfolio of bioavailability enhancement solutions

EUSA Pharma's PROSTASCINT effective in guiding targeted prostate cancer treatment

PAH patients face life-threatening risks from medication errors

GSK's malaria vaccine trial containing Antigenics’ Stimulon adjuvant enrolls more than 5,000 children

Watson Pharmaceuticals announces third quarter 2009 financial results

Medivir presents OPERA-1 Phase IIa trial data at the AASLD meeting

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News